Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The R3 Vascular Drug-Eluting Bioresorbable Scaffold in Below the Knee Vessels Trial (RESOLV I)

NCT04912323 is registered in ClinicalTrials.gov with R3 Vascular Inc. as lead sponsor.

NCT NCT04912323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04912323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The R3 Vascular Drug-Eluting Bioresorbable Scaffold in Below the Knee Vessels Trial (RESOLV I)
Lead sponsor
R3 Vascular Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
August 17, 2021
Completion date
December 31, 2031
Enrollment
30 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic lesion, lower extremity claudication, lower extremity ischemia, peripheral arterial disease